A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease

INTRODUCTION: Dry eye disease is characterized by a persistently unstable or deficient tear film causing discomfort or visual impairment. Varenicline is a small-molecule nicotinic acetylcholine receptor agonist recently approved for use as a preservative-free nasal spray (OC-01 [varenicline solution...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieckmann, Gabriela M., Cox, Stephanie M., Lopez, Maria J., Ozmen, M. Cuneyt, Yavuz Saricay, Leyla, Bayrakutar, Betul N., Binotti, William W., Henry, Eugenia, Nau, Jeffrey, Hamrah, Pedram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253229/
https://www.ncbi.nlm.nih.gov/pubmed/35653029
http://dx.doi.org/10.1007/s40123-022-00530-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253229/
https://www.ncbi.nlm.nih.gov/pubmed/35653029
http://dx.doi.org/10.1007/s40123-022-00530-x

Ejemplares similares